A Single-Center, Randomized, Double-Blind, 3-Period Cross-Over Trial to Compare the Effect of Insulin Glulisine, Insulin Lispro and Unmodified Human Insulin on the Endogenous Glucose Production in Type 1 Diabetic Patients.
Phase of Trial: Phase I
Latest Information Update: 17 Dec 2009
At a glance
- Drugs Insulin; Insulin glulisine; Insulin lispro
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Sanofi
- 17 Dec 2009 Actual initiation date (Apr 2004) added as reported by ClinicalTrials.gov.
- 17 Dec 2009 Actual end date (May 2004) added as reported by ClinicalTrials.gov.
- 12 Sep 2006 New trial record.